Combined with the findings showing the risk of HF hospitalization can be predicted by loop diuretic dosage and NT-proBNP levels, this study may help clinicians identify which ATTR patients could benefit the most from SGLT2i treatment. Here, NPPB is linked to hydrops fetalis.